Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 23971 AL 23985

Comparison of two preprocessing methods for (18)F-Flortaucipir PET quantification in Alzheimer's disease

Harput E, Peretti DE, Scheffler M, Ashton NJ, Blennow K, Zetterberg H, Smith R, Frisoni GB, Garibotto V, Boccalini C.

Eur J Nucl Med Mol Imaging. 2025 Dec;53(1):480-490. doi: 10.1007/s00259-025-07452-3. Epub 2025 Jul 19.

High circulating adropin levels predict long-term blood pressure variability in old adults: evidence from the Multidomain Alzheimer Prevention Trial

Aggarwal G, Salas J, Vellas B, Nguyen AD, Butler AA; MAPT/IHU HealthAge Open Science Group.

Am J Physiol Heart Circ Physiol. 2025 Dec 1;329(6):H1684-H1692. doi: 10.1152/ajpheart.00763.2025. Epub 2025 Nov 18.

Comparative analysis of Elecsys and ELISA for differentiating amyloid-PET status in a Korean memory clinic based on cerebrospinal fluid biomarkers

Park SA, An YS, Park YJ, Lee JY, Jeon H, Kim YS, Lee K, Sun K, Lee SM, Moon SY.

J Alzheimers Dis. 2025 Mar;104(1):232-244. doi: 10.1177/13872877251314886. Epub 2025 Feb 16.

[Research progress and clinical application potential of silicon-based microring resonators in biomedical detection]

Wang Y, Zhao F.

Sheng Wu Gong Cheng Xue Bao. 2025 Apr 25;41(4):1309-1322. doi: 10.13345/j.cjb.240702.

Comparison of multi-miRNA models from donor-matched plasma and cerebrospinal fluid as candidate biomarkers for Alzheimer's disease prediction

Sandau US, Wiedrick JT, McFarland TJ, Chen S, Quinn JF, Saugstad JA.

Sci Rep. 2025 Dec 24;16(1):3207. doi: 10.1038/s41598-025-33589-0.

Concordance between amyloid PET and CSF biomarkers in clinical setting: a cross-platform comparison and in-depth analysis of discordant cases

Cerman J, Škorvagová A, Vyhnálek M, Veverová K, Dvořák K, Kozák Š, Kavka A, Hort J.

Sci Rep. 2025 Nov 14;15(1):39963. doi: 10.1038/s41598-025-23759-5.

Dysregulation of the molecular clock by blood-borne factors in Alzheimer's disease patients

Zhao C, Li T, Hao S, Zhao L, Han Y, Cai Y.

J Neurol. 2025 Jan 15;272(2):121. doi: 10.1007/s00415-024-12824-0.

Proper Name Recall as an Early Indicator of Preclinical Alzheimer Disease Pathology

Mueller KD, Soldan A, Langhough R, Bruno D, Jauregi-Zinkunegi A, Basche K, Hale MR, He D, Moghekar A, Hermann B, Albert M, Pettigrew C.

Alzheimer Dis Assoc Disord. 2025 Oct-Dec 01;39(4):269-276. doi: 10.1097/WAD.0000000000000695. Epub 2025 Nov 10.

Association of neighborhood disadvantage with Alzheimer's disease pathology and the stability of blood-based biomarker performance

Myoraku A, Hausle I, Mila-Aloma M, Thropp P, Wang LA, Doraiswamy PM, Tosun D; Alzheimer’s Disease Neuroimaging Initiative*.

J Prev Alzheimers Dis. 2026 Feb;13(2):100445. doi: 10.1016/j.tjpad.2025.100445. Epub 2025 Nov 23.

The potential role of machine learning and deep learning in differential diagnosis of Alzheimer's disease and FTD using imaging biomarkers: A review

Mirabian S, Mohammadian F, Ganji Z, Zare H, Hasanpour Khalesi E.

Neuroradiol J. 2025 Oct;38(5):571-587. doi: 10.1177/19714009251313511. Epub 2025 Jan 9.

Validation status of cognitive digital assessments by the FDA BEST framework and context of use in preclinical AD studies: A systematic review

Porta-Mas C, Grau-Rivera O, Gispert JD, Blasco GS, Sánchez-Benavides G.

Alzheimers Dement. 2025 Dec;21(12):e70753. doi: 10.1002/alz.70753.

Amyloid Clearance and Transient CSF Aβ40 Reduction in a Case of ARIA-E/H Following Lecanemab Treatment

Naeshiro Y, Kitani-Morii F, Kasai T, Tanaka E, Kobayashi F, Ohara T.

Intern Med. 2026 Apr 1;65(7):1056-1060. doi: 10.2169/internalmedicine.6070-25. Epub 2025 Aug 21.

Clinimetrics: Towards a diagnostic neuropsychology grounded in Alzheimer's disease

Ilardi CR.

J Neuropsychol. 2026 Mar;20(1):246-255. doi: 10.1111/jnp.70008. Epub 2025 Aug 13.

Measurement Error and Methodologic Issues in Analyses of the Proportion of Variance Explained in Cognition

Nichols E, Aslanyan V, Adrien TV, Andrews RM, Fardo DW, Gavett BE, Paterson TSE, Turney IC, Young CB, Uanhoro JO, Gross AL, Initiative FTADN.

Neuropsychol Rev. 2025 Dec;35(4):731-744. doi: 10.1007/s11065-024-09655-1. Epub 2024 Nov 20.

[Advances in measurements and standardization of plasma phosphorylated tau217 as a biomarker for Alzheimer's disease]

Liu HY, Lin YL.

Zhonghua Yu Fang Yi Xue Za Zhi. 2025 Dec 6;59(12):2209-2215. doi: 10.3760/cma.j.cn112150-20250331-00265.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias